These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17320192)

  • 1. Comparisons of glucose-insulin homeostasis following maprotiline and fluoxetine treatment in depressed males.
    Chen YC; Shen YC; Hung YJ; Chou CH; Yeh CB; Perng CH
    J Affect Disord; 2007 Nov; 103(1-3):257-61. PubMed ID: 17320192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy.
    Dam M; Tonin P; De Boni A; Pizzolato G; Casson S; Ermani M; Freo U; Piron L; Battistin L
    Stroke; 1996 Jul; 27(7):1211-4. PubMed ID: 8685930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile.
    Martényi F; Dossenbach M; Mraz K; Metcalfe S
    Eur Neuropsychopharmacol; 2001 Jun; 11(3):227-32. PubMed ID: 11418283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
    Amelin AV; Skoromets AA; Korenko LA; Tumelevich BCh; Gonchar MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(8):20-3. PubMed ID: 10983362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.
    Andreoli V; Caillard V; Deo RS; Rybakowski JK; Versiani M
    J Clin Psychopharmacol; 2002 Aug; 22(4):393-9. PubMed ID: 12172339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
    Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
    Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
    Ko HC; Lu RB; Shiah IS; Hwang CC
    Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A; Roose S
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
    Taner E; Demir EY; Cosar B
    Adv Ther; 2006; 23(6):974-87. PubMed ID: 17276965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Placebo to antidepressant effects ratio by electroencephalographic data].
    Bochkarev VK; Avedisova AS; Liupaeva NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(11):42-8. PubMed ID: 15581036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity.
    Atkinson JH; Slater MA; Wahlgren DR; Williams RA; Zisook S; Pruitt SD; Epping-Jordan JE; Patterson TL; Grant I; Abramson I; Garfin SR
    Pain; 1999 Nov; 83(2):137-45. PubMed ID: 10534584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males.
    Chen YC; Lin WW; Chen YJ; Mao WC; Hung YJ
    Mediators Inflamm; 2010; 2010():573594. PubMed ID: 20490354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
    Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
    Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA
    J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
    Manoharan A; Shewade DG; Rajkumar RP; Adithan S
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.